CA.DI. GROUP S.P.A.

ASAMAX is indicated for the treatment of intestinal inflammation (such as ulcerative colitis and Crohn's disease) and for the prevention of relapses. Depending on the pharmaceutical form, it can be used to treat inflammation at the rectal or rectosigmoid level.

Dosage form: tablets, enteric-coated

ATC: A07EC02